The IOP reductions in the ripasudil and placebo groups were analyzed with a repeated-measures analysis of variance model at weeks @ , @ , and @ , at trough ( before instillation -LSB- @ am -RSB- ) and peak ( @ hours after instillation -LSB- @ am -RSB- ) levels .